BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4216036)

  • 1. Standardized production in goats of antilymphocyte globulin and its clinical use.
    Sheil AG; Mears DC; Kelley GE
    Prog Biochem Pharmacol; 1974; 9():99-106. PubMed ID: 4216036
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled trial antilymphocyte globulin therapy (ALG) in man.
    Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG
    Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 4. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjunct antilymphocyte globulin therapy in canine renal allograft recipients: importance of preoperative administration.
    Kelly GE; Drummond M; Sheil AG
    J Surg Res; 1974 Jun; 16(6):620-3. PubMed ID: 4599465
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-reactivity studies of horse, goat and rabbit anti-lymphocyte globulin.
    Ameniya H; Kashiwagi N; Putnam CW; Starzl TE
    Clin Exp Immunol; 1970 Feb; 6(2):279-89. PubMed ID: 4985160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical trial of antilymphocyte globulin in renal transplantation. Failure to observe a significant improvement.
    Dormont J; Kreis H; Leski M; Bach JF; Crosnier J
    Rev Eur Etud Clin Biol; 1972 Apr; 17(4):382-9. PubMed ID: 4627946
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet complement fixation: an in vitro test of the immunosuppressive activity of antilymphocyte globulin.
    Balfour IC; Pegrum GD; Williams GB; Balner H
    Transplantation; 1972 Sep; 14(3):308-10. PubMed ID: 4629282
    [No Abstract]   [Full Text] [Related]  

  • 9. The production of immunosuppressive antisera.
    Barnes AD; Hawker RJ; Cowdall EI; Dickerson C; Dukes H; Griffin J; Crozier B; Fejfar J; Robinson BH; Blainey JD
    Proc Eur Dial Transplant Assoc; 1972; 9():364-70. PubMed ID: 4204156
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitigation of hyperacute rejection by antilymphocyte globulin (ALG).
    Hammer C; Krebs G; Chaussy C; Pfeifer K; Schmidt K; Land W; Brendel W
    Transplant Proc; 1979 Mar; 11(1):31-5. PubMed ID: 377651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency and maintenance in antilymphocyte globulin fractionation: contrasting tests of effectiveness in an animal model.
    Salerni B; Simmonian SJ; Kay RG; Latham WC; Brown KJ; Birtch AG; Busch GJ; Lukl P; Woods JE
    Surg Forum; 1970; 21():277-9. PubMed ID: 4936983
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation and clinical use of type specific goat antihuman lymphocyte globulin.
    Alexander JW; McCoy HV; Dionigi R; Smith EJ
    Surg Forum; 1969; 20():250-2. PubMed ID: 4910587
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of in vitro, immunosuppressive and clinical effects of goat and horse anti-human thymocyte globulin in Macaca monkeys.
    Kelly GE; Sheil AG; Mears DC
    Clin Exp Immunol; 1973 Apr; 13(4):585-94. PubMed ID: 4197827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroid treatment of rejection in kidney transplantation. A new approach including long-term treatment of rejection with antilymphoblast globulin in a high risk population.
    Toledo-Pereyra LH; Mittal VK; Baskin S; McNichol LJ; Whitten JI
    Transplantation; 1982 Mar; 33(3):325-7. PubMed ID: 6801834
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antilymphocyte globulin today].
    Brendel W
    Munch Med Wochenschr; 1973 Feb; 115(7):241-8. PubMed ID: 4632641
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical use of antilymphocyte serum in organ and tissue allotransplantation (survey of the literature)].
    Korenevskaia VA; Shumakov VI
    Khirurgiia (Mosk); 1972 Feb; 49(2):127-31. PubMed ID: 4572233
    [No Abstract]   [Full Text] [Related]  

  • 17. The antigenic and immunosuppressive properties of normal and antilymphocytic equine IgG subfractions.
    Allardyce RA; Anderson NF; Vaerman JP; James K
    Clin Exp Immunol; 1973 Feb; 13(2):263-78. PubMed ID: 4120853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of goat ATLG and ASLG in human renal transplants.
    Alexander JW; Smith EJ; McAdams AJ; Fidler JP; First MR; Muthiah V; Alexander NS; Korelitz J
    J Surg Res; 1975 Nov; 19(5):287-95. PubMed ID: 1105003
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients].
    Galvão MM; Mendes NF; Ramos OL; Sabbaga E
    Rev Bras Pesqui Med Biol; 1972; 5(5):251-8. PubMed ID: 4573042
    [No Abstract]   [Full Text] [Related]  

  • 20. Gamma globulin fragments in urine of kidney transplant patients in relation to rejection crisis.
    Hermann G; Zühlke V; Faul P
    Eur Surg Res; 1970; 2(1):55-63. PubMed ID: 4131420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.